LYB vs NBIX · P/E 21, rev $16.37B vs P/E 45, rev $1.77B
LyondellBasell Industries NV (LYB) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LYB currently screens at market cap $19.93B and trailing P/E 21.5. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LYB and NBIX stock pages for the full models.
Not investment advice.